A Phase 2 Study of Fludarabine and Intermediate Dose Total Body Irradiation (800 cGy) Followed by Post-Transplant Cyclophosphamide in Patients Aged 18-65 Undergoing Allogeneic Stem Cell Transplant for Hematologic Malignancies